How to forge the core competitiveness in the face of "internal and external attack"?

[editor's point of view of chinapharma.com] in two days, China's diplomacy performed a "hat trick", which made Mongolia, Norway and Sao Tome "soft" Although the situations of the three countries are different and unrelated, they all have something in common, that is, the three countries are committed to developing their trade relations with the world's second largest economy Foreign media commented that "China is making use of its strong economic power as a strategic weapon and making remarkable diplomatic achievements." Economy has gradually become the core advantage of our country It has accelerated the pace of China's opening to the outside world and helped China to solve the tough problems in the crucial stage of reform Under this influence, as an important part of the national economy, the development of the pharmaceutical industry is also concerned, and the core competitiveness has become a key factor in the market competition of pharmaceutical enterprises With the continuous development of pharmaceutical industry and the official promulgation and implementation of relevant policies, Chinese pharmaceutical production has entered a more scientific and systematic era, which also drives the continuous improvement of the technical level of pharmaceutical machinery industry However, due to the late start and relatively low ability of independent research and development, there are still serious homogenization and high concentration of sales market in China's pharmaceutical machinery products In order to compete for market share, some pharmaceutical machinery enterprises will not hesitate to reduce their prices and occupy the market in the way of small profits and high sales In addition, compared with the foreign pharmaceutical machinery industry, domestic enterprises still have a large gap in technology research and development and product design At home, the domestic pharmaceutical machinery equipment has excess capacity, and there are more middle and low-end products; at abroad, foreign enterprises continue to take a strong "attack" to expand the market in China In the face of internal and external attack, Chinese pharmaceutical machinery enterprises still need to work hard to form and enhance their core competitiveness, so as to promote the sustainable development of themselves and the industry It is reported that many enterprises have taken active actions, such as dongfulong, Qianshan pharmaceutical machinery, chutianren, Guangzhou santuo, etc These enterprises are aware of the importance of core competitiveness, combined with the market demand, have increased innovation, extend the industrial chain to improve the ability of innovation and R & D It has always been the core of the development of an industry to form the core competitiveness and transform the technological innovation to the equipment market How can pharmaceutical machinery enterprises make a difference in the international market competition of the weak meat and the strong food? In a word, technological innovation, in particular, can rely on manufacturing standards and technology Some insiders pointed out that "only by mastering the right to formulate standards can Chinese enterprises get rid of the status of being trapped If Chinese enterprises want to be based on the international market, they should be brave to layout the middle market." Taking the pharmaceutical machinery of traditional Chinese medicine as an example, the Dongfeng policy promotes the pharmaceutical industry of traditional Chinese medicine to be better all the way, and also drives the market of pharmaceutical machinery of traditional Chinese medicine to expand continuously But like the progress of science and technology in any field, the quality control of traditional Chinese medicine pharmaceutical machinery still has a process of continuous innovation and improvement of standards China is a big country of traditional Chinese medicine, with rich resources People pay more and more attention to the health preservation of traditional Chinese medicine, and the pace of internationalization and modernization of traditional Chinese medicine is gradually accelerating All these favorable conditions make traditional Chinese medicine pharmaceutical machinery have great potential If enterprises can aim at this breakthrough, innovate in this kind of machinery research and development, and change to the equipment market, it will bring new business opportunities Only by innovating and constantly producing new products can pharmaceutical machinery enterprises seize the market opportunity If the company achieves the basic monopoly market position and forms the core competitiveness in some products, the enterprise will get rich innovation returns If we continue to be complacent and self-contained and only rely on the existing products to participate in the market competition, we will inevitably be eliminated with the change of the market Pharmaceutical machinery enterprises should be alert to this Conclusion: with the rapid development of science and technology, the competitiveness of pharmaceutical machinery enterprises increasingly depends on their technological innovation ability Innovative technology not only has a broad market prospect, but also can be transformed into a strong product or service ability At present, some pharmaceutical machinery enterprises invest too little capital in R & D, which makes R & D ignored, leading to backward technology and difficult to form the core technology capability of enterprises Therefore, enterprises should promote the formation of mechanism, attach importance to the cultivation of high-tech talents, improve the participation and enthusiasm of talents, and strive to become the main body of scientific and technological innovation, so as to enter the market scuffle with a stronger attitude.